IQV
IQVIA Holdings Inc. · Healthcare · Medical - Diagnostics & Research
Momentum inputs (comparable managers):
holder breadth +5.0% ·
share flow +13.6% ·
net new positions +4.8%
· formula
Broad accumulation: rising shares across more holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q4 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q3 2026 | 3 | 0 | 393.01K | $104.01M | n/a | −2 |
| Q2 2026 | 164 | +9 | 122.10M | $23.56B | +12 | −4 |
| Q1 2026 | 159 | -11 | 122.65M | $21.04B | +3 | −15 |
| Q4 2025 | 169 | +1 | 132.77M | $29.93B | +3 | −1 |
| Q3 2025 | 26 | -1 | 77.42M | $14.69B | +1 | −3 |
| Q2 2025 | 25 | +2 | 68.72M | $10.83B | +2 | n/a |
| Q1 2025 | 20 | -1 | 30.89M | $5.44B | n/a | −1 |
| Q4 2024 | 21 | +1 | 31.11M | $6.11B | +1 | n/a |
| Q3 2024 | 19 | -1 | 19.49M | $4.61B | +1 | −2 |
| Q2 2024 | 20 | n/a | 21.58M | $4.56B | n/a | n/a |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Harris Associates (Oakmark) ✦ | 11.34M | +11.4% | $2.23B | 3.7% | ▲ Add | 3 | SEC ↗ ×2 |
| 2 | State Street Global Advisors ✦ (passive) | 7.88M | n/a | $1.55B | 0.1% | n/c | 1 | SEC ↗ |
| 3 | Geode Capital Management ✦ (passive) | 4.18M | +1.9% | $818.31M | 0.1% | ▲ Add | 3 | SEC ↗ ×2 |
| 4 | Norges Bank ✦ (passive) | 1.71M | +1.3% | $336.04M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 5 | Millennium Management ✦ | 1.37M | +301.6% | $269.33M | 0.2% | ▲ Add | 3 | SEC ↗ |
| 6 | D. E. Shaw & Co. ✦ | 965.30K | +211.2% | $189.69M | 0.2% | ▲ Add | 3 | SEC ↗ ×2 |
| 7 | Marshall Wace ✦ | 954.29K | +85.4% | $187.53M | 0.2% | ▲ Add | 3 | SEC ↗ ×3 |
| 8 | Two Sigma Investments ✦ | 767.98K | +98.4% | $150.92M | 0.4% | ▲ Add | 3 | SEC ↗ |
| 9 | Capital World Investors ✦ | 587.87K | -11.8% | $115.52M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 10 | AQR Capital Management ✦ | 427.24K | +125.3% | $83.96M | 0.1% | ▲ Add | 3 | SEC ↗ ×5 |
| 11 | PRIMECAP Management ✦ | 294.99K | -9.5% | $57.97M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 12 | T. Rowe Price ✦ | 288.51K | -30.1% | $56.70M | 0.0% | ▼ Trim | 3 | SEC ↗ ×2 |
| 13 | Citadel Advisors ✦ | 87.94K | -37.0% | $17.28M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 14 | Markel Group ✦ | 58.73K | 0.0% | $11.54M | 0.1% | Held | 3 | SEC ↗ |
| 15 | Renaissance Technologies ✦ | 46.85K | -26.3% | $9.21M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 16 | Adage Capital Partners ✦ | 38.86K | +63.7% | $7.64M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 17 | Arrowstreet Capital ✦ | 37.76K | -21.8% | $7.42M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 18 | Gotham Asset Management ✦ | 31.36K | +11.8% | $6.16M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 19 | Duquesne Family Office ✦ | 21.50K | New | $4.22M | 0.1% | New | 1 | SEC ↗ |
| 20 | Fisher Asset Management ✦ | 15.70K | +112.2% | $3.08M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 21 | Wellington Management ✦ | 9.79K | +12.7% | $1.92M | 0.0% | ▲ Add | 3 | SEC ↗ ×2 |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| Duquesne Family Office | $4.22M | 0.1% |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 1,061 holders, 150.48M shares, $24.99B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Officer · 2.67K sh · $697,228
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology